Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SSX2 Antikörper (C-Term)

SSX2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN927674
  • Target Alle SSX2 Antikörper anzeigen
    SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))
    Bindungsspezifität
    • 15
    • 7
    • 6
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 48
    • 3
    • 2
    Human
    Wirt
    • 42
    • 6
    Kaninchen
    Klonalität
    • 45
    • 3
    Polyklonal
    Konjugat
    • 20
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser SSX2 Antikörper ist unkonjugiert
    Applikation
    • 33
    • 13
    • 13
    • 9
    • 6
    • 5
    • 4
    • 4
    • 3
    • 1
    • 1
    Western Blotting (WB)
    Aufreinigung
    Purified
    Immunogen
    SSX2 antibody was raised in rabbit using the C terminal of SSX2 as the immunogen
    Top Product
    Discover our top product SSX2 Primärantikörper
  • Applikationshinweise
    WB: 0.2-1 µg/mL
    Optimal conditions should be determined by the investigator.
    Kommentare

    SSX2 Blocking Peptide, catalog no. 33R-3849, is also available for use as a blocking control in assays to test for specificity of this SSX2 antibody

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Konzentration
    Lot specific
    Buffer
    Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
    Handhabung
    Avoid repeated freeze/thaw cycles.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
  • Target
    SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))
    Andere Bezeichnung
    SSX2 (SSX2 Produkte)
    Hintergrund
    SSX2 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are probably responsible for transforming activity. Two transcript variants encoding distinct isoforms have been identified for this gene. Synonyms: Polyclonal SSX2 antibody, Anti-SSX2 antibody, synovial sarcoma, X breakpoint 2 antibody, HD21 antibody, HOM-MEL-40 antibody, MGC119055 antibody, MGC15364 antibody, MGC3884 antibody, SSX antibody.
Sie sind hier:
Kundenservice